Newsflash

Welcome To
Middle Country Family Medicine Website
.


We Hope You Find
The Website Useful

Flu Season is Upon Us....
Don't forget to schedule an
appointment for a flu shot.

A federal panel recommended Wednesday that all children get an annual flu shot, dramatically expanding the pool of people who are urged to ward off the contagious respiratory illness -- and possibly paving the way for a universal flu shot recommendation.

The Advisory Committee on Immunization Practices, which makes recommendations to the Centers for Disease Control and Prevention, expanded the group of children who should get annual flu shots to include healthy children ages 5-18. Previously, the recommendation included only those 6 months to age 5.

 

Bookmark Us

 
 

Contact Information

Dr. Michael Randall
2539 Middle Country Road

Centereach, New York 11720
Tel:  (631)580-1740
Fax:  (631)580-9155

:: Contact Us ::
:: Directions ::


Plan route with GMaps

Plan your route to us


Visitors Counter

mod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_counter

Home arrow Medical News
Medical News
MedWorm: Swine Flu
MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest headlines from journals and sites in the Swine Flu category.

  • Key Peptides Identified That Could Lead To A Universal Vaccine For Influenza
    Researchers at the University of Southampton, University of Oxford and Retroscreeen Virology Ltd have discovered a series of peptides, found on the internal structures of influenza viruses that could lead to the development of a universal vaccine for influenza, one that gives people immunity against all strains of the disease, including seasonal, avian, and swine flu. Influenza, an acute viral infection, affects hundreds of thousands of people a year and puts an enormous strain on healthcare providers globally... (Source: Health News from Medical News Today)

    MedWorm Message: Register for MedMatcha, MedWorm's medical advertising network, and receive $5 free advertising.



  • Researchers identify key peptides that could lead to a universal vaccine for influenza
    (University of Southampton) Researchers at the University of Southampton, University of Oxford and Retroscreen Virology Ltd have discovered a series of peptides, found on the internal structures of influenza viruses that could lead to the development of a universal vaccine for influenza, one that gives people immunity against all strains of the disease, including seasonal, avian, and swine flu. (Source: EurekAlert! - Social and Behavioral Science)

  • A case of novel swine influenza A (H1N1) pneumonia complicated with virus-associated hemophagocytic syndrome
    Abstract  Influenza related to complications such as pneumonia and encephalitis have sporadically been reported. However, influenza A (H1N1)-virus-associated hemophagocytic syndrome (VAHS) has rarely been reported. A 39-year old woman complained of high fever and was referred to us. Chest infiltrations in both lungs and a positive polymerase chain reaction (PCR) for novel swine-origin influenza A (H1N1) in bronchial alveolar lavage fluid (BALF) specimen was confirmed and she was diagnosed with influenza A (H1N1) pneumonia. Pancytopenia was found, and hemophagocytic syndrome (HPS) was diagnosed by bone marrow aspiration. Following intravenous administration of antiflu drug and combination therapy of steroid pulse and erythromycin IV, the patient?s respiratory dysfunction a...

  • Older adults may be vulnerable to new swine flu virus
    There may be a lot more vulnerability in the population to a new swine influenza virus than was first thought, new Canadian research suggests. (Source: CTV Health)

  • Cross-reactive antibody to swine influenza A(H3N2) subtype virus in children and adults before and after immunisation with 2010/11 trivalent inactivated influenza vaccine in Canada, August to November 2010
    (Source: Eurosurveillance latest news)

  • Wisconsin Scientist Says H5N1 Flu Strain He Created Is Less Dangerous
    A Wisconsin researcher said his team?s version of the H5N1 bird flu virus is not as lethal as that developed by Dutch researchers. (Source: NYT Health)

    MedWorm Message: Register for MedMatcha, MedWorm's medical advertising network, and receive $5 free advertising.



  • How Young Adults Deal With Influenza
    Only about one in five young adults in their late 30s received a flu shot during the 2009-2010 swine flu epidemic, according to a University of Michigan report that details the behavior and attitudes of Generation X. But about 65 percent were at least moderately concerned about the flu, and nearly 60 percent said they were following the issue very or moderately closely... (Source: Health News from Medical News Today)

  • How Generation X Deals with Influenza
    (Ivanhoe Newswire) -- A quarterly research report from the Longitudinal Study of American Youth, The Generation X Report, shows one in five adults in their late 30s received a flu shot during the 2009-2010 swine flu epidemic. (Source: Medical Headlines From Ivanhoe.com)

  • Generation X: How young adults deal with influenza
    (University of Michigan) Only about one in five young adults in their late 30s received a flu shot during the 2009-2010 swine flu epidemic, according to a University of Michigan report that details the behavior and attitudes of Generation X. (Source: EurekAlert! - Social and Behavioral Science)

  • Safety, immunogenicity, and efficacy of an alphavirus replicon-based swine influenza virus hemagglutinin vaccine.
    Authors: Veen RL, Loynachan AT, Mogler MA, Russell BJ, Harris HD, Kamrud KI Abstract A single-cycle, propagation-defective replicon particle (RP) vaccine expressing a swine influenza virus hemagglutinin (HA) gene was constructed and evaluated in several different animal studies. Studies done in both the intended host (pigs) and non-host (mice) species demonstrated that the RP vaccine is not shed or spread by vaccinated animals to comingled cohorts, nor does it revert to virulence following vaccination. In addition, vaccinated pigs develop both specific humoral and IFN-? immune responses, and young pigs are protected against homologous influenza virus challenge. PMID: 22269873 [PubMed - as supplied by publisher] (Source: Vaccine)





Related Items

Medical News Updates


Clinical Trials / Drug Trials News From Medical News Today
Latest Health News and Medical News posted throughout the day, every day.

Brain MRIs May Provide An Early Diagnostic Marker For Dyslexia
Children at risk for dyslexia show differences in brain activity on MRI scans even before they begin learning to read, finds a study at Children's Hospital Boston. Since developmental dyslexia responds to early intervention, diagnosing children at risk before or during kindergarten could head off difficulties and frustration in school, the researchers say...

Human Hookworm Vaccine Trial
The Na-GST-1 antigen, a candidate for the first human hookworm vaccine developed by the Sabin Vaccine Institute (Sabin), has entered a Phase 1 human trial in Brazil, according to Sabin. For the vaccine product development partnership (PDP) headquartered at Sabin, the clinical trial is a considerable achievement. Worldwide, almost 600 million individuals are infected by human hookworm...

Impetigo - Ozenoxacin Phase lll Trial
The pharmaceutical company Ferrer has received approval to start phase III human trials of ozenoxacin, formulated as a topical treatment for infectious skin conditions. In February 2012, participants are expected to enter the multicenter, randomized, placebo controlled, parallel, double-blinded superiority clinical study, which is scheduled to complete in 2013...

New Drug For Advanced Colorectal Cancer Shows Promise In Trial
An experimental drug for advanced colorectal cancer that available treatments have failed to halt, has shown promise in a clinical trial, says Bayer HealthCare, the company that makes it. The results of the phase III trial show that compared to placebo, regorafenib slowed tumor growth and extended survival...

Medivation And Pfizer Axe their new Alzheimer's drug Dimebon
Pfizer Inc. and Medivation, Inc. announced results from their 'CONCERT' trial today. CONCERT is a Phase 3 trial that evaluated dimebon (latrepirdine), which is used to treat patients with mild-to-moderate Alzheimer's disease. Dimebon is added to ongoing treatment with donepezil HCL tablets...

Preoperative Breast Cancer Treatment May Be Improved By Combining 2 Anti-HER2 Drugs
Using two drugs that inhibit the growth factor HER2 for preoperative treatment of early-stage HER2-positive breast cancer appears to have better results than treatment with a single agent...

Research Misconduct Revealed in UK
A BMJ survey revealed that over one in ten (13%) UK based scientists or doctors have witnessed that colleagues intentionally changed or fabricated data during their research in order to get published, whilst 6% of respondents reported they are aware of possible research misconduct at their institution, that has not been accurately investigated...

In Ovarian Cancer, Faulty Proteins May Prove Significant In Identifying New Treatments
OHSU Knight Cancer Institute study results suggest that more patients than initially thought could potentially be treated with a new class of drugs, PARP inhibitors A constellation of defective proteins suspected in causing a malfunction in the body's ability to repair its own DNA could be the link scientists need to prove a new class of drugs will be effective in treating a...

Insurance Providers

medicare.jpg
bluecrossblushield.gif
aetna.jpg
hip.jpg

For a Complete List
Click Here


© 2012 Middle Country Family Medicine
Joomla! is Free Software released under the GNU/GPL License.